부산대학교 도서관

There are of course likely to be elements of each treatment pathway which can be simplified further for patients, in an effort to maximise engagement and reduce potential for treatment fatigue. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial. In non-complicated cases of infection - that is non-cirrhotic - on-site general practitioners (GPs) or nurse practitioners prescribed DAA treatment in line with national guidelines. As we rapidly approach the final years in attempting to meet the World Health Organization (WHO) viral hepatitis elimination goals, only 11 high-income countries are on track to eliminate hepatitis c virus (HCV) as a public health threat by 2030.1,2 Most countries are almost 20 years from achieving this milestone based on current estimates. [Extracted from the article]